This event is open exclusively to NEVCA Members, their portfolio companies, and NEVCA Partner organizations.
This November, the NEVCA teams up with AbbVie to convene distinguished experts for an interactive discussion licensing in a new age of Biotech. This VC Briefing promises can’t-miss content.
Margarita Chavez, AbbVie Ventures
Kevin Bitterman, Atlas
Vivian Berlin, Harvard Office of Technology Development
David T. Scadden MD, Harvard Stem Cell Institute